Filing Details
- Accession Number:
- 0001127602-19-024838
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-18 11:38:19
- Reporting Period:
- 2019-07-15
- Accepted Time:
- 2019-07-18 11:38:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1441876 | Mostafa Ronaghi | 5200 Illumina Way San Diego CA 92122 | Svp & Cto | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-07-15 | 10,000 | $69.34 | 86,776 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-07-15 | 2,717 | $301.16 | 84,059 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-07-15 | 5,716 | $301.93 | 78,343 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-07-15 | 767 | $302.95 | 77,576 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-07-15 | 300 | $304.14 | 77,276 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-07-15 | 500 | $305.40 | 76,776 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2019-07-15 | 10,000 | $0.00 | 10,000 | $69.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,000 | 2011-02-28 | 2021-01-31 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 2,717 shares sold ranging from $300.59 to $301.56 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 5,716 shares sold ranging from $301.60 to $302.53 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 767 shares sold ranging from $302.62 to $303.50 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 300 shares sold ranging from $303.80 to $304.31 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 500 shares sold ranging from $305.02 to $305.92 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.